FILE PHOTO: A U.S. flag stands next to the AstraZeneca logo during a signing event for documents related to a manufacturing site investment at the Meridian International Center in Washington, D.C., ...
Breztri becomes the first single-inhaler triple therapy for patients as young as 12 years ...
AstraZeneca announced in its first-quarter presentation (PDF) on Tuesday that it had stopped working on a phase 1 Alzheimer's disease drug and two phase 2 programs for migraine and osteoarthritis pain ...